Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TYRA is expected to report earnings to rise 11.81% to -48 cents per share on May 01
Q1'25
Est.
$-0.48
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.11
The last earnings report on March 27 showed earnings per share of -43 cents, beating the estimate of -47 cents. With 120.78K shares outstanding, the current market capitalization sits at 535.68M.